Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30147% above fair value
$55.75−0.60 (-1.06%)
Close on Nov 20, 2026Market cap $3.33BP/E –Yield –
Axogen free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Axogen's free cash flow for the twelve months ending Sep 30, 2026 was $22.04M, up 559.7% year over year. For fiscal 2025 it was -$2.93M, down 304.5% from the year before. The highest annual figure on record is $1.43M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.93M | -304.5% |
| FY2024 | Dec 31, 2024 | $1.43M | – |
| FY2023 | Dec 31, 2023 | -$19.59M | – |
| FY2022 | Dec 31, 2022 | -$36.14M | – |
| FY2021 | Dec 31, 2021 | -$41.22M | – |
| FY2020 | Dec 31, 2020 | -$31.53M | – |
| FY2019 | Dec 31, 2019 | -$24.54M | – |
| FY2018 | Dec 31, 2018 | -$24.14M | – |
| FY2017 | Dec 31, 2017 | -$10.34M | – |
| FY2016 | Dec 31, 2016 | -$12.17M | – |
| FY2015 | Dec 31, 2015 | -$13.46M | – |
| FY2014 | Dec 31, 2014 | -$10.99M | – |
| FY2013 | Dec 31, 2013 | -$10.62M | – |
| FY2012 | Dec 31, 2012 | -$8.71M | – |
| FY2011 | Dec 31, 2011 | -$7.10M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $15.14M | +789.3% |
| Q2 FY2026 | Jun 30, 2026 | $6.33M | -9.7% |
| Q1 FY2026 | Mar 31, 2026 | -$1.22M | – |
| Q4 FY2025 | Dec 31, 2025 | $1.79M | -77.8% |
| Q3 FY2025 | Sep 30, 2025 | $1.70M | -48.5% |
| Q2 FY2025 | Jun 30, 2025 | $7.01M | +115.3% |
| Q1 FY2025 | Mar 31, 2025 | -$13.44M | – |
| Q4 FY2024 | Dec 31, 2024 | $8.07M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.30M | – |
| Q2 FY2024 | Jun 30, 2024 | $3.26M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.06M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.73M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.26M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.06M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.74M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.68M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.09M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.52M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.92M | – |
| Q4 FY2020 | Dec 31, 2020 | -$161.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.11M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.19M | – |
| Q1 FY2020 | Mar 31, 2020 | -$13.07M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.32M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.86M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.35M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.21M | – |
| Q3 FY2018 | Sep 30, 2018 | -$8.36M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.37M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.20M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.54M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.41M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.34M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.05M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.77M | – |
See a number that looks wrong?